Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Liu

Showing results (491-500 of 502) with videos related to

Pageof 51
Sort By:
Cell Reports|April 20, 2025
KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathwayJia-Ming Wang, Feng-Hao Zhang, Hai-Yun Xie, et al.
International Journal of Cancer|March 15, 2023
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trialTie Zhou, Shengfei Qin, Weidong Xu, et al.
Genome Biology|October 31, 2023
Landscape of enhancer disruption and functional screen in melanoma cellsZhao Wang, Menghan Luo, Qian Liang, et al.
Environmental Science & Technology|October 24, 2024
Characteristics of Nocturnal Boundary Layer over a Subtropical Forest: Implications for the Dispersion and Fate of Atmospheric SpeciesShaojie Jiang, Yaying Wang, Xiangpeng Huang, et al.
BMC Cancer|April 16, 2020
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)Hai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Annals of Surgical Oncology|November 18, 2024
Multimodality Therapy and Survival Outcomes in Resectable Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective StudyLei Xu, Yu-Shang Yang, Bin Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanismAlexandra Zanin-Zhorov, Jonathan M Weiss, Melanie S Nyuydzefe, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 8, 2025
Preventing Glioblastoma Relapse by Igniting Innate Immunity through Mitochondrial Stress in the Surgical CavityXu Han, Fan Feng, Zixu Wang, et al.
Annals of Translational Medicine|February 8, 2021
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)Yan Zheng, Xian-Ben Liu, Hai-Bo Sun, et al.
JAMA Oncology|April 21, 2022
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell TransplantQamar J Khan, Cory R Bivona, Grace A Martin, et al.
Pageof 51

Showing results (491-500 of 502) with videos related to

Sort By:
Pageof 51
Cell Reports|April 20, 2025
KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathwayJia-Ming Wang, Feng-Hao Zhang, Hai-Yun Xie, et al.
International Journal of Cancer|March 15, 2023
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trialTie Zhou, Shengfei Qin, Weidong Xu, et al.
Genome Biology|October 31, 2023
Landscape of enhancer disruption and functional screen in melanoma cellsZhao Wang, Menghan Luo, Qian Liang, et al.
Environmental Science & Technology|October 24, 2024
Characteristics of Nocturnal Boundary Layer over a Subtropical Forest: Implications for the Dispersion and Fate of Atmospheric SpeciesShaojie Jiang, Yaying Wang, Xiangpeng Huang, et al.
BMC Cancer|April 16, 2020
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)Hai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Annals of Surgical Oncology|November 18, 2024
Multimodality Therapy and Survival Outcomes in Resectable Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective StudyLei Xu, Yu-Shang Yang, Bin Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanismAlexandra Zanin-Zhorov, Jonathan M Weiss, Melanie S Nyuydzefe, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 8, 2025
Preventing Glioblastoma Relapse by Igniting Innate Immunity through Mitochondrial Stress in the Surgical CavityXu Han, Fan Feng, Zixu Wang, et al.
Annals of Translational Medicine|February 8, 2021
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)Yan Zheng, Xian-Ben Liu, Hai-Bo Sun, et al.
JAMA Oncology|April 21, 2022
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell TransplantQamar J Khan, Cory R Bivona, Grace A Martin, et al.
Pageof 51